Monopar Therapeutics Inc. (MNPR)
NASDAQ · Healthcare
Monopar Therapeutics Inc. annual/quarterly total liabilities history from 2016 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Monopar Therapeutics Inc. total liabilities for the quarter ending December 31, 2025 were 2.9M, a 44.99% decrease year-over-year.
- Monopar Therapeutics Inc. total liabilities for 2025 were 2.9M, a 44.99% decrease from 2024.
- Monopar Therapeutics Inc. total liabilities for 2024 were 5.3M, a 625.57% increase from 2019.
- Monopar Therapeutics Inc. total liabilities for 2019 were 724,165, a 81.24% increase from 2018.
- Monopar Therapeutics Inc. total liabilities for 2018 were 399,551.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Monopar Therapeutics Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $3 |
| 2024 | $5 |
| 2019 | $1 |
| 2018 | $0 |
| 2017 | $0 |
| 2016 | $0 |
| Monopar Therapeutics Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $3 |
| 2024-12-31 | $5 |
| 2019-12-31 | $1 |
| 2018-12-31 | $0 |
| 2017-12-31 | $0 |
| 2016-12-31 | $0 |
Monopar Therapeutics Inc. Total Liabilities — FAQ
Monopar Therapeutics Inc. (MNPR) total liabilities over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see MNPR's total liabilities history?
The chart and table above show Monopar Therapeutics Inc.'s total liabilities by year and by quarter, including the growth rate.